Showing results (351-360 of 505) with videos related to

Sort By:
Pageof 51
International Journal of Clinical Pharmacology and Therapeutics|October 19, 2004
Population pharmacokinetics of methylprednisolone in accident victims with spinal cord injuryJ Barth, J Winkler, R Schumann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 21, 2016
PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal CancerDavid C Qian, Xiangjun Xiao, Jinyoung Byun, et al.
Cancers|March 13, 2024
Ex Vivo Fluorescence Confocal Microscopy of MRI-Guided Targeted Prostate Biopsies for Rapid Detection of Clinically Significant Carcinomas-A Feasibility StudyUlf Titze, Barbara Titze, Torsten Hansen, et al.
Molecular Pharmaceutics|July 18, 2009
Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performanceOlivia M Merkel, Andrea Beyerle, Damiano Librizzi, et al.
The Journal of Rheumatology|July 1, 1995
Anti-CENP-B response in sera of uranium miners exposed to quartz dust and patients with possible development of systemic sclerosis (scleroderma)K Conrad, G Stahnke, B Liedvogel, et al.
Oral Oncology|October 29, 2004
Effectiveness of radiochemotherapy on lymph node metastases in patients with stage IV oropharyngeal cancerNikolay R Sapundzhiev, Peter J Barth, Peter Vacha, et al.
Cancer Research|July 1, 1997
Protective immunity induced by tumor vaccines requires interaction between CD40 and its ligand, CD154M F Mackey, J R Gunn, P P Ting, et al.
Virchows Archiv : an International Journal of Pathology|May 27, 2008
Pathogenesis of lymphangiomasSusanne Wiegand, Behfar Eivazi, Peter J Barth, et al.
Archives of Surgery (Chicago, Ill. : 1960)|May 1, 1991
Level of axillary involvement by lymph node metastases from breast cancer is not an independent predictor of survivalR J Barth, D N Danforth, D J Venzon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2010
A randomized trial of ex vivo CD40L activation of a dendritic cell vaccine in colorectal cancer patients: tumor-specific immune responses are associated with improved survivalRichard J Barth, Dawn A Fisher, Paul K Wallace, et al.
Pageof 51